<DOC>
	<DOCNO>NCT03022708</DOCNO>
	<brief_summary>This multi-center prospective , single-arm , non-randomized , open label study assess feasibility Xeltis Bioabsorbable Pulmonary Valved Conduit subject require Right Ventricular Outflow Tract correction reconstruction due congenital heart malformation .</brief_summary>
	<brief_title>Xeltis Bioabsorbable Pulmonary Valved Conduit Early Feasibility Study</brief_title>
	<detailed_description />
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<criteria>1 . Patient require RVOT reconstruction , suitable 16 mm 18 mm valved conduit . 2 . Male Female . 3 . Age &gt; 2 year &lt; 22 year . 4 . Right Ventricular Pulmonary Artery peak gradient &gt; 35mm Hg moderate severe Pulmonary regurgitation ( ≥3+ ) , . 5 . The patient , patient 's parent / legal representative appropriate , informed nature study , agree provision provide write informed consent sign approve informed consent form . 6 . The patient , patient 's parent / legal representative appropriate , treat physician agree subject return require postprocedure follow visit subject comply clinical investigation plan require followup visit . 1 . Need presence prosthetic heart valve position . 2 . Need concomitant surgical procedure ( noncardiac ) . 3 . Patients previously implant pacemaker ( include defibrillator ) , mechanical valve . 4 . Active infection require current antibiotic therapy ( temporary illness , subject may candidate 4 week discontinuation antibiotic ) viral infection . 5 . Active endocarditis . 6 . Leukopenia , define White Blood cell Count &lt; : 212 year : 5.0 ×103 /μL 12 year Adult : Male : 4.5×103 /μL Female : 4.5 ×103 /μL 7 . Acute chronic anemia , define Hemoglobin &lt; : 212 year 11.5 g /dl 1218 : Male : 13 g /dl Female 12 g /dl Adult : Male : 13.5 g /dl Female : 12 g /dl Patients transfuse meet eligibility criterion 8 . Thrombocytopenia , define Platelet count &lt; : 150,000/mm3 Patients transfused meet eligibility criterion 9 . Severe chest wall deformity , would preclude placement PV conduit . 10 . Pulmonary hypertension ( ≥ half systemic systolic pressure ) 11 . Right ventricular outflow tract aneurysm . 12 . Known hypersensitivity anticoagulant antiplatelet drug device material . . 13 . Immunocompromised patient define : autoimmune disease , patient receive immunosuppressant drug immune stimulant drug . 14 . Subject chronic inflammatory / autoimmune disease . 15 . Need emergency cardiac vascular surgery intervention . 16 . Major progressive noncardiac disease ( liver failure , renal failure , cancer ) life expectancy le one year . 17 . Currently participate , participate within last 30 day , investigational drug device study . 18 . Alcohol drug abuse define DSM IVTR criterion substance abuse include illicit use cannabis within last 12 month . 19 . Pregnancy . 20 . Females sexually active willing use adequate contraceptive precaution next 2 year 21 . Subject medical , social psychosocial factor , opinion Investigator , could impact safety compliance .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>